BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29683103)

  • 21. [The active middle ear implant for the rehabilitation of sensorineural, mixed and conductive hearing losses].
    Sprinzl GM; Wolf-Magele A; Schnabl J; Koci V
    Laryngorhinootologie; 2011 Sep; 90(9):560-72. PubMed ID: 21913153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse events and discomfort during magnetic resonance imaging in cochlear implant recipients.
    Kim BG; Kim JW; Park JJ; Kim SH; Kim HN; Choi JY
    JAMA Otolaryngol Head Neck Surg; 2015 Jan; 141(1):45-52. PubMed ID: 25411817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome of round window Vibrant SoundBridge implantation in extensive ossicular chain defects.
    Colletti L; Mandalà M; Colletti V
    Otolaryngol Head Neck Surg; 2013 Jul; 149(1):134-41. PubMed ID: 23585147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active middle ear implants in patients undergoing subtotal petrosectomy: new application for the Vibrant Soundbridge device and its implication for lateral cranium base surgery.
    Linder T; Schlegel C; DeMin N; van der Westhuizen S
    Otol Neurotol; 2009 Jan; 30(1):41-7. PubMed ID: 18849883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vibrant Soundbridge for hearing restoration after chronic ear surgery.
    Streitberger C; Perotti M; Beltrame MA; Giarbini N
    Rev Laryngol Otol Rhinol (Bord); 2009; 130(2):83-8. PubMed ID: 19813469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Belgian experience with the Vibrant Soundbridge prosthesis.
    Thill MP; Gérard JM; Garin P; Offeciers E
    Acta Otorhinolaryngol Belg; 2002; 56(4):375-8. PubMed ID: 12528257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging compatibility and safety of the SOUNDTEC Direct System.
    Dyer RK; Nakmali D; Dormer KJ
    Laryngoscope; 2006 Aug; 116(8):1321-33. PubMed ID: 16885731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MR compatibility of Med EL cochlear implants: clinical testing at 1.0 T.
    Youssefzadeh S; Baumgartner W; Dorffner R; Gstöttner W; Trattnig S
    J Comput Assist Tomogr; 1998; 22(3):346-50. PubMed ID: 9606372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term assessment after implantation of the Vibrant Soundbridge device.
    Schmuziger N; Schimmann F; àWengen D; Patscheke J; Probst R
    Otol Neurotol; 2006 Feb; 27(2):183-8. PubMed ID: 16436987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vibroplasty in mixed and conductive hearing loss: comparison of different coupling methods.
    Vyskocil E; Riss D; Honeder C; Arnoldner C; Hamzavi JS; Baumgartner WD; Flak S; Gstoettner W
    Laryngoscope; 2014 Jun; 124(6):1436-43. PubMed ID: 24338550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active middle-ear implant fixation in an unusual place: clinical and audiological outcomes.
    Polanski JF; Soares AD; Dos Santos ZM; Mendonça Cruz OL
    J Laryngol Otol; 2016 Apr; 130(4):404-7. PubMed ID: 26991877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Torque measurements of the ossicular chain: implication on the MRI safety of the hearing implant Vibrant Soundbridge.
    Jesacher MO; Kiefer J; Zierhofer C; Fauser C
    Otol Neurotol; 2010 Jun; 31(4):676-80. PubMed ID: 20142797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noise in magnetic resonance imaging: no risk for sensorineural function but increased amplitude variability of otoacoustic emissions.
    Wagner W; Staud I; Frank G; Dammann F; Plontke S; Plinkert PK
    Laryngoscope; 2003 Jul; 113(7):1216-23. PubMed ID: 12838022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Audiogram and cochlear implant candidacy--UK perspective.
    Chundu S; Flynn SL
    Cochlear Implants Int; 2014 Jul; 15(4):241-4. PubMed ID: 24144046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of the atretic ear with round window vibrant soundbridge implantation in infants and children: electrocochleography and audiologic outcomes.
    Mandalà M; Colletti L; Colletti V
    Otol Neurotol; 2011 Oct; 32(8):1250-5. PubMed ID: 21897320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of magnetic resonance imaging on internal magnet strength in Med-El Combi 40+ cochlear implants.
    Wackym PA; Michel MA; Prost RW; Banks KL; Runge-Samuelson CL; Firszt JB
    Laryngoscope; 2004 Aug; 114(8):1355-61. PubMed ID: 15280707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The benefit of the reverse transfer function in the fitting process of the Vibrant Soundbridge middle ear implant.
    Karkas A; Chahine K; Schmerber S
    Acta Otolaryngol; 2012 Feb; 132(2):173-8. PubMed ID: 22074549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of the "floating mass transducer" in the middle ear on hearing sensitivity.
    Snik FM; Cremers WR
    Am J Otol; 2000 Jan; 21(1):42-8. PubMed ID: 10651434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Speech recognition and communication outcomes with cochlear implantation in Usher syndrome type 3.
    Pietola L; Aarnisalo AA; Abdel-Rahman A; Västinsalo H; Isosomppi J; Löppönen H; Kentala E; Johansson R; Valtonen H; Vasama JP; Sankila EM; Jero J
    Otol Neurotol; 2012 Jan; 33(1):38-41. PubMed ID: 22143301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Auditory cortical responses evoked by pure tones in healthy and sensorineural hearing loss subjects: functional MRI and magnetoencephalography.
    Zhang YT; Geng ZJ; Zhang Q; Li W; Zhang J
    Chin Med J (Engl); 2006 Sep; 119(18):1548-54. PubMed ID: 16996009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.